Network Growth Infinity Laboratories is now part of the Eurofins network, expanding capabilities and regulatory support for biopharmaceutical and medical device developers. Sales opportunity: cross-sell Eurofins testing services, leverage broader network reach, and position as a single-source partner for quality, safety, and compliance testing.

Regulatory support Expanded service portfolio with regulatory support across medical devices and biopharmaceuticals. Sales angle: offer end-to-end compliance solutions, method validation, and GMP-aligned testing programs to accelerate product development timelines.

Real-time Testing Recent launch of Mycoplasma testing using real-time PCR highlights capability in rapid, high-sensitivity assays. Growth play: target pharma and device manufacturers needing fast microbial contamination screening and faster time-to-market.

Leadership & scale New leadership appointment in commercial operations and the Eurofins backing provide credibility for enterprise-level clients. Sales tactic: approach mid-to-large biotech and medical device firms seeking robust, scalable contract testing partnerships with proven leadership.

Acquisition momentum Past acquisitions and strategic partnerships indicate an active expansion trajectory and integration capabilities. Opportunity: approach potential clients seeking a partner with established acquisition synergies, breadth of services, and seamless onboarding.